Back

Mavacamten for worsening left ventricular outflow tract obstruction after TAVI in a patient with hypertrophic cardiomyopathy

28 August 2026 (11:33 - 11:45)
Organised by: Logo
Congress Presentation Part of: Hypertrophic cardiomyopathy: from diagnosis to therapy Clinical ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Masato Takeuchi

Kochi Medical School, Kochi University, Nankoku (Japan)

4 More presentations in this session

Presentation thumbnail
Early haemodynamic response but persistent systolic dysfunction after mavacamten interruption in obstructive hypertrophic cardiomyopathy (oHCM): a pharmacist led titration case
Miss D. Lakhani (London, GB)
Slides Video
Presentation thumbnail
A young female patient with massive LVH and dual-level obstructive HCM: a case report on the successful use of mavacamten and future management planning
Doctor D. Da Silva Correia (Lisbon, PT)
Slides Video
Presentation thumbnail
Unusual genetics in hypertrophic cardiomyopathy: looking beyond autosomal dominant inheritance
Doctor S. Rivas Garcia (Madrid, ES)
Slides Video
Presentation thumbnail
Hypertrophic cardiomyopathy phenotype associated with concomitant gla, ttr and prkag2 variants in an amazonian adolescent
Doctor I. Peterlini Valsi (Sao Paulo, BR)
Slides Video

Access the full session

Session thumbnail
Hypertrophic cardiomyopathy: from diagnosis to therapy
Video

The Event

Event poster

ESC Congress 2026

28 August 2026 11:33 CET
You may be interested in
thumbnail
Congress Presentation
Mavacamten therapy in hypertrophic obstructive cardiomyopathy revealing severe aortic stenosis: a case highlighting diagnostic complexity
11 May 2026
thumbnail
Congress Session
Transcatheter valve repairements
28 August 2023
thumbnail
Congress Presentation
Utilising mavacamten to mitigate post TAVR suicide left ventricle risk in patient with concomitant severe aortic stenosis, hypertrophic obstructive cardiomyopathy, and severe coronary artery disease.
31 August 2025
thumbnail
Congress Presentation
Takotsubo syndrome after pacemaker implantation in hypertensive cardiomyopathy requiring beta-blockade: when treatment creates new challenges.
29 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources